Hjem › Crohns sykdom › Kentucky › Louisville
Kliniske studier for Crohns sykdom i Louisville, KY
9 studier for Crohns sykdom søker deltakere på steder i og rundt Louisville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruttererFase 2
- Gastroenterology Health Partners /ID# 284144, Louisville
- Gastroenterology Health Partners /ID# 284145, New Albany · 4 mi unna
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RekruttererFase 3
- University of Louisville Hospital ( Site 5120), Louisville
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 2
- University Of Louisville, Louisville
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 2/3
- University of Louisville - MedCenter One, Louisville
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RekruttererFase 3
- Gastroenterology Health Partners, Louisville
- Gastroenterology Health Partners, New Albany · 4 mi unna
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 3
- Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100, New Albany · 4 mi unna
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 3
- Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100, New Albany · 4 mi unna
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RekruttererFase 4
- University of Louisville, Louisville
Treatment of Moderate to Severe Refractory Crohn's Disease
RekruttererFase 1/2
- University of Louisville, Louisville
Crohns sykdom-studier i andre byer
- New York City, NY35 studier
- Boston, MA19 studier
- Miami, FL19 studier
- Cleveland, OH19 studier
- St. Louis, MO19 studier
- Tyler, TX17 studier
- Houston, TX17 studier
- Orlando, FL17 studier
- Atlanta, GA17 studier
- San Antonio, TX15 studier
- San Diego, CA15 studier
- Los Angeles, CA15 studier
Andre studier i Louisville
- Ikke-småcellet lungekreft22 studier
- Fedme17 studier
- Overvekt15 studier
- Kreft (alle typer)14 studier
- Hjertesvikt13 studier
- Akut myelogen leukemi12 studier
- Multipelt myelom12 studier
- Eggstokkreft12 studier
- Brystkreft11 studier
- Plateepitelcancer i hode og hals11 studier
- Lungekreft11 studier
- Melanom10 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.